00241.HK
Alibaba Health Information Technology Limited
HKSE · Healthcare · Medical - Pharmaceuticals · HK
HKD 3.07
+4.07%Year over year
Reported trailing growth
- Revenue
- —
- EBITDA
- —
- EBIT
- —
- EPS
- —
- Free cash flow
- —
- Operating cash flow
- —
Forward estimates
Based on analyst estimates
- Revenue
- —
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- +8.6%
- EBITDA
- +20.2%
- EBIT
- +60.0%
- Net income
- +53.5%
- EPS
- +44.6%
- Free cash flow
- +70.0%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Mar 1, 2026